Quicking Biotech Co., Ltd. has established itself as a premier manufacturer and supplier of high-quality rapid diagnostic test kits, serving healthcare institutions, laboratories, and governments across the globe. With years of accumulated expertise in the in-vitro diagnostics industry, the company has built a reputation for delivering reliable, accurate, and cost-effective testing solutions. Its comprehensive product line covers infectious disease detection, drugs of abuse screening, and food safety analysis, making it a one-stop partner for diagnostic needs. Quicking Biotech holds multiple international certifications including ISO 13485, CE marking, and FDA registration, ensuring that every kit meets rigorous global standards. The company’s state-of-the-art manufacturing facilities and strict quality management systems guarantee batch-to-batch consistency and high performance. Moreover, its global distribution network enables timely delivery to clients in over 100 countries, from hospital networks in Europe to rural clinics in developing regions. By combining technical innovation with a customer-first philosophy, Quicking Biotech continues to drive advancements in point-of-care testing and public health protection. For more insight into the company’s mission and milestones, visit theAbout Us page, which details its founding in 2006 and its relentless pursuit of excellence. The organization’s dedication to quality and speed has made it a preferred partner for ministries of health, NGOs, and private sector buyers seeking dependable rapid test solutions.

Quicking Biotech offers an extensive menu of rapid test kits that cover a wide spectrum of medical and environmental testing requirements. In the infectious disease category, the company provides tests for COVID-19, HIV, malaria, dengue, hepatitis B and C, syphilis, and many other pathogens. For sexually transmitted infections, the RPR test is a widely used serological screening tool that helps detect syphilis quickly and accurately, making it indispensable in public health programs. The rapid antigen test for COVID remains one of the company’s most requested products, praised for its high sensitivity and ability to deliver results in under 20 minutes. Additionally, the portfolio includes tests for respiratory infections like influenza and RSV, as well as gastrointestinal diseases such as typhoid and cholera. In the drugs of abuse segment, Quicking produces urine-based rapid test panels that screen for substances including THC, cocaine, opiates, amphetamines, and benzodiazepines, offering multi-panel configurations for workplace and clinical settings. For food safety professionals, the company supplies rapid tests for allergens (e.g., gluten, peanut, milk) and mycotoxins (e.g., aflatoxin, ochratoxin), enabling on-site quality checks without laboratory delays. One notable product is the Monospot test, used for the rapid diagnosis of infectious mononucleosis caused by the Epstein-Barr virus, which is especially valuable in outpatient clinics and student health centers. The breadth of the catalog allows buyers to source virtually all their rapid diagnostic needs from a single, trusted supplier. Customization options such as private labeling, custom cassette designs, and tailored panel combinations are available for distributors and OEM partners. To explore the full range of available tests, visit theProducts page, where each category is displayed with detailed specifications and intended use.

What sets Quicking Biotech’s rapid test kits apart from competitors is the combination of high diagnostic accuracy, fast turnaround time, and ease of use. Every test is engineered to deliver sensitivity and specificity levels that meet or exceed WHO and FDA performance benchmarks, ensuring clinicians can trust the results for critical treatment decisions. The lateral flow technology employed in most cassettes and strips provides clear, easy-to-read lines that minimize the risk of misinterpretation, even for operators with minimal training. Results are typically available within 15 to 20 minutes, which is essential for emergency rooms, urgent care centers, and field deployment where time is a limiting factor. For example, the rapid strep test, used to diagnose group A streptococcal pharyngitis, allows healthcare providers to prescribe appropriate antibiotics immediately rather than waiting 24–48 hours for culture results. This speed reduces unnecessary antibiotic use and improves patient outcomes. The test kits are designed for room-temperature storage with a shelf life of 18 to 24 months, eliminating the need for refrigeration and simplifying logistics in remote areas. Bulk packaging options are available for high-volume buyers, reducing per-unit costs and waste. Quicking also offers ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) services, enabling clients to launch their own branded product lines without investing in R&D infrastructure. Competitive pricing structures make the kits accessible to both developed and emerging markets. Additionally, the company continuously invests in R&D to improve test sensitivity against emerging variants and new pathogens. The overall user experience is enhanced by clear instructions, minimal sample preparation, and disposable components that meet biosafety requirements. All these features contribute to why healthcare procurement managers consistently choose Quicking Biotech as their long-term rapid test supplier.

Quality is the cornerstone of Quicking Biotech’s operations, and the company maintains a fully integrated in-house research and development team that works continuously to optimize test performance. The manufacturing facilities operate under Good Manufacturing Practice (GMP) guidelines and are equipped with automated production lines that ensure consistent product quality across millions of test units. Raw materials, including nitrocellulose membranes, gold conjugates, and antibody pairs, are sourced from certified global suppliers and subjected to incoming quality checks before production begins. During the manufacturing process, every batch undergoes multiple quality control tests, such as sensitivity validation, specificity analysis, accelerated aging studies, and lot-to-lot reproducibility checks. The company’s quality management system is certified to ISO 13485, the international standard for medical device quality, and many products carry CE marking for the European market. FDA registration for select test kits further demonstrates compliance with the most stringent regulatory frameworks. In addition to internal controls, Quicking participates in external proficiency testing programs and collaborates with reference laboratories to validate product performance. For the rapid antigen test for COVID, the company conducted clinical trials in multiple countries to confirm accuracy against RT-PCR reference methods, publishing data that supports its use in mass screening campaigns. The quality assurance team also monitors post-market surveillance, collecting feedback from users to drive continuous improvement. Every shipment includes a certificate of analysis upon request, giving buyers full traceability and confidence. To stay updated on the latest quality certifications, product validations, and company news, visit theNews page, which features regular updates on regulatory approvals and industry recognitions.

Quicking Biotech’s rapid test kits are deployed across a wide variety of healthcare and public health settings, from high-throughput hospital laboratories to remote field clinics with limited infrastructure. In hospital emergency departments, the rapid strep test is used routinely to differentiate bacterial pharyngitis from viral sore throats, enabling fast, targeted antibiotic therapy and reducing patient wait times. Primary care clinics and pediatric offices rely on these tests for same-day diagnosis, improving patient satisfaction and clinical workflow. For infectious disease control, the rapid antigen test for COVID-19 has been instrumental in mass screening programs at airports, schools, workplaces, and community testing centers, where quick results are essential for infection containment. The RPR test is a cornerstone of antenatal screening programs in many countries, helping prevent congenital syphilis by identifying infected pregnant women early. Public health laboratories use the Monospot test for rapid confirmation of infectious mononucleosis in adolescents and young adults, avoiding the need for more expensive serological panels. In the field of food safety, Quicking’s allergen and toxin test kits allow food manufacturers to screen raw materials and finished products on-site, preventing contaminated products from reaching consumers. Veterinary clinics also benefit from the company’s animal health diagnostic kits, which detect diseases in livestock and companion animals. The portability and stability of the kits make them ideal for mobile health units, disaster relief operations, and military field hospitals. Point-of-care testing in pharmacies and home-use testing are growing application areas, empowered by the simple, non-invasive sample collection methods (nasal swab, oral fluid, urine, or blood). The versatility of the product range ensures that every testing environment—whether urban or rural, high-resource or low-resource—can access the same high-quality diagnostic tools.

Quicking Biotech views every client relationship as a long-term partnership, providing comprehensive support that goes well beyond the initial sale. A dedicated customer service team is available to answer technical questions, assist with product selection, and provide troubleshooting guidance in multiple languages. The company offers detailed product inserts, instructional videos, and training materials that help end users achieve accurate results from the very first use. For new distributors, Quicking provides marketing support including catalog content, presentation templates, and product brochures in customized formats. Logistics are managed through a global network of shipping partners, with inventory held in regional warehouses to reduce transit times and customs complexity. Standard orders are processed within 24 to 48 hours, and bulk shipments are tracked in real time. The company’s location in Shanghai, China, provides access to major international shipping hubs, enabling cost-effective freight options whether by air, sea, or courier. For clients interested in private labeling, the ODM/OEM team guides them through the entire process—from packaging design and regulatory documentation to artwork approval and production scheduling. Quicking also supports tender submissions for government and institutional contracts, providing all necessary documentation including CE certificates, ISO certifications, and lot-specific quality reports. The company actively seeks exclusive distribution partners in under-served regions and offers tiered pricing for volume commitments. By combining product excellence with responsive service, Quicking Biotech has earned the loyalty of hundreds of repeat buyers worldwide. To initiate a partnership, request samples, or inquire about bulk pricing, visit theNew Page contact form, where you can send a direct message to the sales team.

If your organization is searching for a reliable, ISO-certified manufacturer of rapid diagnostic test kits, Quicking Biotech Co., Ltd. is ready to support your mission. Whether you need a single product for a specific disease screening program or a complete catalog for distribution across multiple markets, the company has the experience, capacity, and flexibility to deliver. Bulk orders are welcomed with competitive discount structures, and sample kits are available for evaluation before committing to large volumes. Distributors seeking exclusive territorial rights, private label partners wanting to build their own brand, and government agencies preparing for public health tenders will all find a responsive and professional counterpart at Quicking. The team can provide customized product configurations, such as multi-parameter panels that combine a rapid antigen test for COVID with influenza A/B in a single cassette, increasing testing efficiency during respiratory season. For laboratory managers evaluating alternatives to traditional serology, the RPR test and Monospot test from Quicking offer the same clinical utility as reference methods but at a fraction of the cost and time. Food safety and veterinary testing buyers will also find dedicated support and specialized product lines tailored to their sectors. To take the next step, contact Quicking Biotech by email at info@quickingivd.com, by phone at +86-21-5860-1998, or through the official website athttps://www.quickingivd.com. The sales team typically responds within 12 business hours and can arrange video calls to discuss technical specifications, certification documents, and logistics plans in detail. Don’t let diagnostic delays compromise patient care or operational efficiency—partner with a global leader that puts quality, speed, and customer success first.

A rapid test is a diagnostic device that detects the presence of specific antigens or antibodies in a sample (such as blood, saliva, or urine) within a short time, typically 15–20 minutes. Most rapid tests use lateral flow technology, where the sample migrates along a membrane and produces a visible colored line if the target analyte is present. Quicking Biotech manufactures a wide range of rapid test kits that are designed for simplicity, requiring no additional equipment or laboratory infrastructure.

Yes, Quicking Biotech’s products carry CE marking for the European market, and select test kits are registered with the FDA. The company’s quality management system is ISO 13485 certified, and each product undergoes rigorous validation to meet international performance standards. Buyers can request certificates of conformity and regulatory documentation for specific kits during the inquiry process.

The rapid strep test is designed for professional use in clinical settings, but some versions may be suitable for trained home users. Quicking Biotech provides clear instructions with each kit, and the test requires a throat swab collected by a healthcare professional or a properly instructed user. For accurate diagnosis, it is always recommended to follow the test procedure exactly and consult a doctor for treatment decisions.

Quicking Biotech’s rapid antigen test for COVID-19 has demonstrated high sensitivity (typically above 90%) and specificity (above 98%) in clinical studies when compared to RT-PCR as the reference method. While PCR remains the gold standard for detection, rapid antigen tests are highly effective for identifying infectious individuals, especially during the early symptomatic phase. They are widely recommended for mass screening and point-of-care use by WHO and CDC guidelines.

The RPR test (rapid plasma reagin) is a serological screening test for syphilis, a sexually transmitted infection caused by Treponema pallidum. It is commonly used in antenatal care, STI clinics, and blood donor screening. A positive result requires confirmatory testing with a treponemal-specific assay. Quicking Biotech offers a reliable RPR test kit with clear, easy-to-read results within 20 minutes.

The monospot test is a rapid diagnostic test for infectious mononucleosis, which is caused by the Epstein-Barr virus (EBV). It detects heterophile antibodies in the blood and is typically used in adolescents and young adults presenting with fever, sore throat, and lymphadenopathy. Quicking Biotech's monospot test kit provides results in minutes, aiding in fast clinical decision-making without the need for complex laboratory equipment.

Yes, Quicking Biotech provides comprehensive ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) services. Clients can customize packaging, cassette designs, test panel configurations, and branding. The company supports the entire process from artwork development to regulatory documentation, making it easy for distributors to launch their own product lines under their brand name.

Most Quicking Biotech rapid test kits have a shelf life of 18 to 24 months from the date of manufacture. They should be stored at room temperature (2–30°C) in a dry environment, away from direct sunlight and extreme humidity. No refrigeration is required, which simplifies storage and distribution in regions with limited cold chain infrastructure.

To request samples or inquire about bulk pricing, you can contact Quicking Biotech via email at info@quickingivd.com, call +86-21-5860-1998, or fill out the contact form on the New Page. The sales team typically responds within 12 business hours and can assist with product selection, pricing, and shipping arrangements.

Absolutely. Quicking Biotech offers comprehensive technical support including product inserts, instructional videos, troubleshooting guides, and online training sessions for new partners. For large-scale deployments or government programs, the company can provide on-site training or virtual workshops to ensure correct usage and accurate results across all testing sites.